WaveMan · Form 4
Broadwood Partners, L.P. insider trades
> Search tickers & screens ⌘K
LIVE

Broadwood Partners, L.P. insider trades

Broadwood Partners, L.P. has filed 13 Form 4s with the SEC that we hold, for Insight Molecular Diagnostics Inc. (IMDX) (10% owner), Staar Surgical Co (STAA) (10% owner) and Lineage Cell Therapeutics, Inc. (LCTX) (Director, 10% owner). Across all of them we count 24 purchases worth $72.8M and 0 sales worth $0 reported on Form 4. In the last 12 months: 3 purchases ($2.0M) and 0 sales ($0). The largest single trade was a purchase of 4,505,488 shares of Insight Molecular Diagnostics Inc. worth $9.2M, dated 2025-02-06. The first filing on our record is dated 2021-09-24 and the latest 2026-04-27.

Insight Molecular Diagnostics Inc. (IMDX)

10% owner · 6 filings · 8 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-04-14P, purchase reported on Form 46,003,752$8.0M2022-04-15
2023-04-03P, purchase reported on Form 426,827,638$8.0M2023-04-05
2024-04-11P, purchase reported on Form 42,420,000$7.1M2024-04-15
2025-02-06P, purchase reported on Form 4660,207$1.4M2025-02-10
2025-02-06P, purchase reported on Form 44,505,488$9.2M2025-02-10
2026-04-23P, purchase reported on Form 4280,381$981.3K2026-04-27
2026-04-24P, purchase reported on Form 438,880$137.2K2026-04-27
2026-04-27P, purchase reported on Form 4250,923$913.4K2026-04-27

Staar Surgical Co (STAA)

10% owner · 6 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-27P, purchase reported on Form 451,985$2.5M2022-12-29
2022-12-28P, purchase reported on Form 4100,000$4.7M2022-12-29
2022-12-29P, purchase reported on Form 439,090$1.9M2022-12-29
2024-01-03P, purchase reported on Form 46,573$190.2K2024-01-05
2024-01-04P, purchase reported on Form 463,246$1.8M2024-01-05
2024-01-05P, purchase reported on Form 4156,634$4.5M2024-01-05
2024-01-05P, purchase reported on Form 4100$2.9K2024-01-05
2024-05-09P, purchase reported on Form 41$432024-05-13
2025-03-31P, purchase reported on Form 422,189$387.4K2025-04-02
2025-04-02P, purchase reported on Form 431,780$553.9K2025-04-02
2025-04-03P, purchase reported on Form 4209,535$3.6M2025-04-07
2025-04-04P, purchase reported on Form 45,000$82.3K2025-04-07
2025-04-04P, purchase reported on Form 4492,631$7.8M2025-04-07
2025-04-07P, purchase reported on Form 411,589$185.2K2025-04-07
2025-04-07P, purchase reported on Form 4126,465$2.0M2025-04-07

Lineage Cell Therapeutics, Inc. (LCTX)

Director, 10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2024-02-06P, purchase reported on Form 46,730,770$7.0M2024-02-08
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1278386) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms